Annals of Clinical and Translational Neurology (Apr 2024)

Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington's disease

  • Hiba Bilal,
  • Stuart J. McDonald,
  • Julie C. Stout,
  • Ian H. Harding

DOI
https://doi.org/10.1002/acn3.52016
Journal volume & issue
Vol. 11, no. 4
pp. 989 – 999

Abstract

Read online

Abstract Objective Huntington's disease (HD) is an inherited neurodegenerative disease involving progressive motor abnormalities, cognitive decline, and psychiatric disturbances. Depression and cognitive difficulties are among the most impactful symptoms of HD, yet the pathogenesis of these symptoms is not fully understood. HD involves low‐level chronic inflammation and dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, which are linked to depression and cognitive impairment in non‐HD populations. However, previous research on the relationships of these pathologies with depression and cognition in HD is limited and inconsistent. Methods Fifty‐three adults with the HD gene expansion (30 premanifest and 23 manifest) completed measures of depression and cognitive functioning. Forty‐eight out of 53 participants provided hair samples for quantification of cortisol, and 34 participants provided blood samples for quantification of peripheral inflammatory cytokines. We examined the associations of four cytokines (interleukin [IL]‐6, IL‐10, IL‐1β, and tumor necrosis factor [TNF]‐α) and cortisol levels with depression and cognitive scores. Results In unadjusted models, higher levels of plasma IL‐6, IL‐10, and TNF‐α correlated with higher depression scores, and higher levels of IL‐10 and TNF‐α correlated with poorer cognitive performance. After controlling for age, sex, and body mass index, only the correlations of IL‐10 with depression and cognitive performance remained significant. No correlations were evident with hair cortisol. Interpretations Peripheral inflammation is associated with depression symptoms and cognitive impairment in HD. Our findings suggest that interactions between the immune and nervous systems are important in HD, and highlight the potential of chronic inflammation as a therapeutic target in early stages of HD.